Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives
A meeting that was organized by the Academy of Pharmaceutical Sciences Biopharmaceutics and Regulatory Sciences focus groups focused on the challenges of Developing Clinically Relevant Dissolution Specifications (CRDS) for Oral Drug Products. Industrial Scientists that were involved in product devel...
Main Authors: | Mark McAllister, Talia Flanagan, Karin Boon, Xavier Pepin, Christophe Tistaert, Masoud Jamei, Andreas Abend, Evangelos Kotzagiorgis, Claire Mackie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/1/19 |
Similar Items
-
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
by: Mark McAllister, et al.
Published: (2022-05-01) -
Revisiting the Dissolution of Praziquantel in Biorelevant Media and the Impact of Digestion of Milk on Drug Dissolution
by: Thomas Eason, et al.
Published: (2022-10-01) -
Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
by: Gustavo Vaiano Carapeto, et al.
Published: (2023-05-01) -
Optimization of Dissolution Compartments in a Biorelevant Dissolution Apparatus Golem v2, Supported by Multivariate Analysis
by: Ivan Stupák, et al.
Published: (2017-11-01) -
Biorelevant test for supersaturable formulation
by: Enxian Lu, et al.
Published: (2017-01-01)